Alpha Cognition

TSXV:ACOG
Request Investor Info

Alpha Cognition is a clinical stage, biopharmaceutical company. They’re dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).

Projects
Stories
Presentation
Contact
Management
Financials
Alpha Cognition Stock Price Today
Alpha Cognition Fundamental Data by TradingView

Company Feed

May 10, 2022

Alpha Cognition: Alzheimer’s Treatment with Minimal Side Effects

This is some text inside of a div block.
Alpha Cognition
September 1, 2021

Alpha Cognition: Therapy for Alzheimer’s Dementia

Alpha Cognition is a clinical stage, biopharmaceutical company. They're dedicated to developing treatments for under-served neurodegenerative diseases …

This is some text inside of a div block.
Alpha Cognition
August 27, 2021

Alpha Cognition: Focused on Neurodegenerative Diseases

Alpha Cognition is a clinical-stage, biopharmaceutical company. Their main focus is to develop treatments for neurodegenerative diseases, like Alzheim …

This is some text inside of a div block.
Alpha Cognition Alzeihmer's Disease
May 13, 2020

Alpha Cognition: Alzheimer’s Treatment with Minimal Side Effects

Alpha Cognition Inc. is a privately held biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and sp …

This is some text inside of a div block.
Subscribe and receive the investor Info